IP Verse

Cubist Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Cubist Pharmaceuticals opposed by its competitors

Explore Cubist Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2504353
Sep 13, 2023Lipopeptide Compositions And Related Methods2

Latest publications and patents of Cubist Pharmaceuticals New

Explore the latest publications and patents granted to Cubist Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cubist Pharmaceuticals

EP2504353
Sep 13, 2023Lipopeptide Compositions And Related MethodsPatent Maintained As Amended

Latest PTAB cases involving Cubist Pharmaceuticals

Discover the latest PTAB cases involving Cubist Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 25, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Cubist Pharmaceuticals

IPR2020-00193Nov 27, 2019AMNEAL PHARMACEUTICALSCUBIST PHARMACEUTICALSInstitution Denied
IPR2015-01566Jul 10, 2015FRESENIUS KABI USACUBIST PHARMACEUTICALSTerminated-Settled
IPR2015-01570Jul 10, 2015FRESENIUS KABI USACUBIST PHARMACEUTICALSTerminated-Settled
IPR2015-01571Jul 10, 2015FRESENIUS KABI USACUBIST PHARMACEUTICALSTerminated-Settled
IPR2015-01572Jul 10, 2015FRESENIUS KABI USACUBIST PHARMACEUTICALSInstitution Denied
IPR2015-00223Nov 3, 2014FRESENIUS KABI USACUBIST PHARMACEUTICALSFinal Written Decision
IPR2015-00227Nov 3, 2014FRESENIUS KABI USACUBIST PHARMACEUTICALSFinal Written Decision
IPR2015-00144Oct 24, 2014AGILA SPECIALTIESCUBIST PHARMACEUTICALSInstitution Denied
IPR2015-00131Oct 23, 2014AGILA SPECIALTIESCUBIST PHARMACEUTICALSInstitution Denied
IPR2015-00132Oct 23, 2014AGILA SPECIALTIESCUBIST PHARMACEUTICALS INCORPORATEDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Cubist Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CUBIST PHARMACEUTICALS - 2 - 13
AGILA SPECIALITIES - - 4 -
AGILA SPECIALTIES - - 5 -
FRESENIUS KABI USA - - 265